WML-13929-60621 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-27
Dose 1 — Pfizer-BioNTech
2021-10-14
Dose 2 — Pfizer-BioNTech
2021-11-17
Registered in v-safe
2021-11-17
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-11-18
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-11-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-01-13
Survey response — 3 months, dose 2
MedDRA: Cough, Nasal congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cough, stuffy/runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-04-14
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-27	Pfizer-BioNTech	No
2	2021-10-14	Pfizer-BioNTech	No

Free text

Release 10 — 3 months, dose 2

2022-01-13

Symptoms: Cough, stuffy/runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release